Genmab A/S
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2022 | — | $3.92B | $1.42B |
| FY2023 | $0 | $4.69B | $2.20B |
| FY2024 | $0 | $5.14B | $1.38B |
| FY2025 | $5.00B | $5.85B | $1.72B |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2022 | — | $3.92B | $1.42B |
| FY2023 | $0 | $4.69B | $2.20B |
| FY2024 | $0 | $5.14B | $1.38B |
| FY2025 | $5.00B | $5.85B | $1.72B |